156 related articles for article (PubMed ID: 29779953)
1. A quality assurance device for measuring afterloader performance and transit dose for nasobiliary high-dose-rate brachytherapy.
Deufel CL; Mullins JP; Zakhary MJ
Brachytherapy; 2018; 17(4):726-731. PubMed ID: 29779953
[TBL] [Abstract][Full Text] [Related]
2. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter.
Deufel CL; Furutani KM; Dahl RA; Grams MP; McLemore LB; Hallemeier CL; Neben-Wittich M; Martenson JA; Haddock MG
Brachytherapy; 2018; 17(4):718-725. PubMed ID: 29776892
[TBL] [Abstract][Full Text] [Related]
3. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
4. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
Simmons DT; Baron TH; Petersen BT; Gostout CJ; Haddock MG; Gores GJ; Yeakel PD; Topazian MD; Levy MJ
Am J Gastroenterol; 2006 Aug; 101(8):1792-6. PubMed ID: 16780552
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent screen for high-dose-rate (HDR) brachytherapy quality assurance.
Lightstone AW
Med Dosim; 2005; 30(3):143-4. PubMed ID: 16112464
[TBL] [Abstract][Full Text] [Related]
6. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
[TBL] [Abstract][Full Text] [Related]
7. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
8. Postoperative endoscopic retrograde high dose-rate brachytherapy for cholangiocarcinoma.
Ove R; Kennedy A; Darwin P; Haluszka O
Am J Clin Oncol; 2000 Dec; 23(6):559-61. PubMed ID: 11202795
[TBL] [Abstract][Full Text] [Related]
9. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a source position checking tool for the quality assurance of transfer tubes used in HDR
Awunor OA
Brachytherapy; 2018; 17(3):628-633. PubMed ID: 29352643
[TBL] [Abstract][Full Text] [Related]
11. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
12. Acceptance testing, commissioning and quality assurance for a 370 GBq 192Ir HDR brachytherapy afterloader.
Wallace AB
Australas Phys Eng Sci Med; 1997 Jun; 20(2):112-6. PubMed ID: 9262031
[TBL] [Abstract][Full Text] [Related]
13. Direct measurement of instantaneous source speed for a HDR brachytherapy unit using an optical fiber based detector.
Minamisawa RA; Rubo RA; Seraide RM; Rocha JR; Almeida A
Med Phys; 2010 Oct; 37(10):5407-11. PubMed ID: 21089776
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
15. The use of radiochromic film to measure dose distributions resulting from high dose rate 192Iridium single catheter treatments.
Skwarchuk MW; Ochran TG; Komaki R; Cundiff J; Travis EL
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):173-81. PubMed ID: 12118548
[TBL] [Abstract][Full Text] [Related]
16. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
17. Fractionated high-dose rate brachytherapy for intracranial gliomas.
Woo S; Butler EB; Grant W; Berner B; Gildenberg P
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):247-9. PubMed ID: 8270447
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
[TBL] [Abstract][Full Text] [Related]
19. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
20. [Intraluminal irradiation with 192Ir source in bile duct carcinoma].
Monzen Y; Ajimu A; Ikenaga K; Sakamoto I; Ishida Y; Aikawa H; Mori H; Hayashi K; Honbo Z
Rinsho Hoshasen; 1988 Oct; 33(10):1103-5. PubMed ID: 3210333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
